NASDAQ · Health care

Coya Therapeutics, Inc. (COYA)

Coya Therapeutics, Inc. brought in $8M of revenue over the twelve months to June 30, 2026, up 1,793.8% from a year earlier. It posted a net loss of $21.7M. At June 30, 2026 it held $43.2M in cash. Its latest periodic report to the SEC is the quarterly report (10-Q) filed on August 11, 2026.

Revenue (last 12 months)

$8M

+1,793.8% year on year

Net margin

-270.2%

What Coya Therapeutics, Inc. does

Coya Therapeutics, Inc. is registered with the SEC under industry code SIC 2834 (Pharmaceutical Preparations). Its shares trade on NASDAQ under the ticker COYA.

Revenue and profit by year

Revenue

Net income

Fiscal years as reported in annual reports. Amounts in USD.

Key figures

Fiscal year	Revenue	Operating income	Net income	Diluted EPS	Free cash flow
2025	$7.9M	-$22.6M	-$21.2M	-$1.27	n/a
2024	$3.6M	-$17.2M	-$14.9M	-$0.98	n/a
2023	$6M	-$7.9M	-$8M	-$0.79	n/a
2022	$0	-$9.8M	-$12.2M	-$4.73	n/a
2022	n/a	-$4.9M	-$4.9M	-$1.89	n/a

Latest SEC filings

What Coya Therapeutics, Inc. has filed recently, newest first. Each links to the original document on SEC EDGAR.

September 15, 2026
Other event 8-K
August 11, 2026
Quarterly report 10-Q · period to June 30, 2026
August 11, 2026
Quarterly results 8-K
August 7, 2026
Executive or director change 8-K/A
July 27, 2026
Passive stake changed SCHEDULE 13G/A
June 25, 2026
Shareholder vote results 8-K
May 13, 2026
Annual report to shareholders ARS
May 13, 2026
Additional proxy material DEFA14A
May 13, 2026
Proxy statement DEF 14A
May 12, 2026
Material agreement 8-K

Recent insider filings (Forms 3, 4 and 144): 10, the latest on April 9, 2026. Insider transactions on SEC

All filings on SEC EDGAR

Questions about COYA

What does Coya Therapeutics, Inc. do?

Coya Therapeutics, Inc. is registered with the SEC under industry code SIC 2834 (Pharmaceutical Preparations). Its shares trade on NASDAQ under the ticker COYA.

Is Coya Therapeutics, Inc. profitable?

No. Over the twelve months to June 30, 2026 it reported a net loss of $21.7M on revenue of $8M.

How much revenue does Coya Therapeutics, Inc. make?

Over the twelve months to June 30, 2026 Coya Therapeutics, Inc. reported revenue of $8M. That is 1,793.8% more than a year earlier.

When did Coya Therapeutics, Inc. last report?

Its most recent periodic report is the quarterly report (10-Q) filed on August 11, 2026. It covers the period to June 30, 2026. Its newest filing of any kind is the other event from September 15, 2026.

Similar companies

Follow COYA

Get an email when Coya Therapeutics, Inc. files with the SEC: results, executive changes, material agreements and annual reports.

Follow COYA: get an email when it files

Where the numbers come from

Financial figures are the values Coya Therapeutics, Inc. tagged in its own SEC filings (XBRL), taken from the latest filing for each period, so restatements replace older figures. Revenue, profit and cash flow are for full fiscal years unless marked as the last twelve months, which is the sum of the four most recent quarters. Where a company reports only the full year, the fourth quarter is the year minus the first three.

Prices are delayed end-of-day market data in the listing currency, and market cap moves with the price. P/E is shown only when earnings per share are positive. Nothing here is investment advice.